Across the country, innovative labs demonstrate that exceptional research doesn’t require unlimited budgets—just smart sourcing strategies.
These seven examples highlight how reliance on surplus lab equipment enabled rapid scaling and breakthrough capabilities:
- A Boston-area synthetic biology startup outfitted a full NGS workflow for under $300k using liquidated sequencers and automation.
- A Midwestern university core facility expanded proteomics capacity by acquiring multiple high-end mass spectrometers at 60% savings.
- An emerging infectious disease lab in the Southeast built BSL-3 capacity with verified biosafety cabinets and autoclaves from recent renovations.
- A West Coast neuroscience group established advanced imaging suites using surplus confocal and two-photon systems.
- A clinical research center accelerated trial timelines by sourcing validated analyzers immediately available through liquidation.
- An environmental testing lab scaled sample throughput with bundled HPLC and GC systems from a single university surplus event.
- A materials science program at a public institution equipped graduate training labs entirely with redirected core-facility instruments.
Common threads: thorough documentation, trusted platforms, and strategic timing. Each achieved capability months or years ahead of traditional procurement timelines—at fractions of projected cost.
These stories illustrate a broader shift: surplus is no longer a compromise but a competitive advantage for agile, resource-conscious teams.
Join the growing number of labs building excellence through smart surplus strategies at ScienceLiquidation.com.
